Agranulocytosis Following Pyribenzamine
- 1 December 1949
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 241 (22) , 865-867
- https://doi.org/10.1056/nejm194912012412205
Abstract
THE effectiveness of Pyribenzamine (tripelennamine hydrochloride) in many allergic states and its apparent freedom from toxicity have led to its widespread use with little fear of serious reaction. Thus far only 1 case of depression of the granulocytic series after Pyribenzamine therapy has been reported.1 The following case is believed to represent agranulocytosis resulting from the use of Pyribenzamine over a period of five and a half weeks.Case ReportA 39-year-old housewife entered the hospital complaining of sore tongue and mouth of 3 days' duration. The past history included migraine headache since the menarche, for which she had frequently . . .Keywords
This publication has 3 references indexed in Scilit:
- GRANULOCYTOPENIA DUE PROBABLY TO "PYRIBENZAMINE"JAMA, 1947
- THE ETIOLOGIC IMPORTANCE OF FATIGUE AND THE PROGNOSTIC SIGNIFICANCE OF MONOCYTOSIS IN NEUTROPENIA (AGRANULOCYTOSIS)The Lancet Healthy Longevity, 1938
- Observations on the Possible Relation between Agranulocytosis and Menstruation with Further Studies on a Case of Cyclic NeutropeniaNew England Journal of Medicine, 1934